Cancer Research · 2016 · 34 citations · 25 references
MedicineCancer BiologyOncologyEpigeneticsEpigenomicsMolecular OncologyCancer EpigeneticsCancer EpigenomicsEpigenetic Alterations In CancerEpigenomic ProfilingKidney CancerRenal Cell CarcinomaChromatin AccessibilityChromatin Accessibility ProfilingEpigenetic Alterations In CarcinogenesisEpigenomic AlterationsEpigenomic AnalysisTherapeutic EpigeneticsVon Hippel-lindau DiseaseVon Hippel-lindau Syndrome
Alterations in chromatin accessibility independent of DNA methylation can affect cancer-related gene expression, but are often overlooked in conventional epigenomic profiling approaches. In this study, we describe a cost-effective and computationally simple assay called AcceSssIble to simultaneously interrogate DNA methylation and chromatin accessibility alterations in primary human clear cell renal cell carcinomas (ccRCC). Our study revealed significant perturbations to the ccRCC epigenome and identified gene expression changes that were specifically attributed to the chromatin accessibility status whether or not DNA methylation was involved. Compared with commonly mutated genes in ccRCC, such as the von Hippel-Lindau (VHL) tumor suppressor, the genes identified by AcceSssIble comprised distinct pathways and more frequently underwent epigenetic changes, suggesting that genetic and epigenetic alterations could be independent events in ccRCC. Specifically, we found unique DNA methylation-independent promoter accessibility alterations in pathways mimicking VHL deficiency. Overall, this study provides a novel approach for identifying new epigenetic-based therapeutic targets, previously undetectable by DNA methylation studies alone, that may complement current genetic-based treatment strategies. Cancer Res; 76(7); 1954-64. ©2016 AACR.
25
Comprehensive molecular characterization of clear cell renal cell carcinoma
A unique chromatin signature uncovers early developmental enhancers in humans
Álvaro Rada-Iglesias, Ruchi Bajpai, Tomek Swigut et al. · Nature · 2010 · 2.3K citations · Full text
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang, Han Han, Daniel D. De Carvalho et al. · Cancer Cell · 2014 · 1.2K citations · Full text